Daito Pharmaceutical News and Activities
Presence
Daito Pharmaceutical develops and manufactures pharmaceutical products, with a focus on generic medicines, active ingredients, and contract manufacturing services for healthcare companies, pharmacies, and medical institutions in Japan and overseas.
Daito Pharmaceutical products and services overview:
- Generic medicines
- Active ingredients
- Contract manufacturing
- Prescription drugs
- OTC medicines
Revenue: ~$400 million
Employees: 900
Headquarters: Toyama, Japan
Daito Pharmaceutical is one of the...
Daito Pharmaceutical is a company listed under the stock ticker 4577 (JP).
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Daito Pharmaceutical
- Hiroshi Matsumori, Chief Executive Officer
- Yasunobu Otsuga, Chairman of the Board
- Ichizo Yamamoto, Independent Director
Create your alert
to follow the executive moves at Daito Pharmaceutical.
Pharmaceuticals
Daito Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Daito Pharmaceutical
Social media about Daito Pharmaceutical
- Daito Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Daito Pharmaceutical on LinkedIn, X (Twitter) & YouTube
